These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


259 related items for PubMed ID: 36565366

  • 1. A Population-Based Helicobacter pylori Eradication Strategy Is More Cost-Effective than Endoscopic Screening.
    Kowada A.
    Dig Dis Sci; 2023 May; 68(5):1735-1746. PubMed ID: 36565366
    [Abstract] [Full Text] [Related]

  • 2. Cost-Effectiveness of Population-Based Helicobacter pylori Screening With Eradication for Optimal Age of Implementation.
    Kowada A.
    Helicobacter; 2024 May; 29(4):e13120. PubMed ID: 39138610
    [Abstract] [Full Text] [Related]

  • 3. Endoscopy Is Cost-Effective for Gastric Cancer Screening After Successful Helicobacter pylori Eradication.
    Kowada A.
    Dig Dis Sci; 2021 Dec; 66(12):4220-4226. PubMed ID: 33417196
    [Abstract] [Full Text] [Related]

  • 4. Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: A cost-effectiveness analysis.
    Kowada A, Asaka M.
    Helicobacter; 2021 Oct; 26(5):e12837. PubMed ID: 34278663
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness of Helicobacter pylori test and eradication versus upper gastrointestinal series versus endoscopy for gastric cancer mortality and outcomes in high prevalence countries.
    Kowada A.
    Scand J Gastroenterol; 2019 Jun; 54(6):685-689. PubMed ID: 31190581
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Both family-based Helicobacter pylori infection control and management strategy and screen-and-treat strategy are cost-effective for gastric cancer prevention.
    Ma J, Yu M, Shao QQ, Yu XC, Zhang C, Zhao JB, Yuan L, Qi YB, Hu RB, Wei PR, Xiao W, Chen Q, Jia BL, Chen CL, Lu H, Ding SZ.
    Helicobacter; 2022 Aug; 27(4):e12911. PubMed ID: 35706404
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Economic and health impacts of Helicobacter pylori eradication strategy for the treatment of peptic ulcer disease: A cost-effectiveness analysis.
    Kowada A, Asaka M.
    Helicobacter; 2022 Jun; 27(3):e12886. PubMed ID: 35343031
    [Abstract] [Full Text] [Related]

  • 14. Cost-Effectiveness Analysis of the Helicobacter Pylori Screening Programme in an Asymptomatic Population in China.
    Feng T, Zheng Z, Xu J, Cao P, Gao S, Yu X.
    Int J Environ Res Public Health; 2022 Aug 13; 19(16):. PubMed ID: 36011621
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Endoscopic screening for gastric cancer.
    Dan YY, So JB, Yeoh KG.
    Clin Gastroenterol Hepatol; 2006 Jun 13; 4(6):709-16. PubMed ID: 16765306
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.